English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Aim: Colonoscopic polypectomy is the most effective visceral cancer prevention tool in clinical medicine. Studies observed a 76-90% reduction in colorectal cancer incidence following colonoscopic polypectomy. We herein present a case series who underwent polypectomy by lower gastrointestinal system (GIS) endoscopy. Methods: The study population consisted of 7503 lower GIS endoscopy (colonoscopy or rectosigmoidoscopy) procedures performed in the Department of General Surgery between 2009 - 2019 for screening, diagnostic and follow-up purposes. 612 (8.2%) of the patients who underwent polypectomy were evaluated. The patients’ demographic data, clinical status, histopathology reports and follow-up findings were recorded. Results: During the study period, 612 patients (38 patients, twice and 3 patients, thrice) underwent polypectomy with lower GIS endoscopy. 386 of the patients were male and 226 were female. The mean age of the patients was 57.3 (13.7) (range 24-89) years. A total of 813 polypectomies were performed, and 118 procedures included two or more polypectomies. The most common sites of polypectomies were rectum (n=233, 29.5%), sigmoid colon (n=208, 25.3%) and the descending colon (n=107, 13%). Histopathological examination revealed 25 adenocarcinomas (4.1%), 98 high grade dysplasias (16%) and 269 low grade dysplasias (44%). In terms of histopathological results, there were no significant differences between genders (p=0.098), however, younger patients (mean age: 51.7 years (14.7)) were more likely to have benign results and malignity was more often encountered in older patients (p<0.001). The mean ages of patients with adenocarcinoma and high-grade dysplasia were 61.2 (12.1) and 63.6 (11.1) years, respectively. Necessary treatments and follow-ups were performed for the related pathologies. Conclusion: We observed that 8.2% of the patients undergoing lower GIS endoscopy had polyps and 20.1% of these polyps needed additional treatment, and 44% needed follow-up colonoscopy control. It should be noted that patients with various lower gastrointestinal tract symptoms may have malign polyps, potentially curable by polypectomy.

Lower gastrointestinal endoscopic polypectomy: Cross-sectional study with 7503 consecutive endoscopic procedures